Oteseconazole (CAS: 1340593-59-0)

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Oteseconazole Reduce the incidence rate ofrecurrent vulvovaginal candidiasis MycoviaPharmaceuticals  Apr.22,2031


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us